Cetera Advisors LLC Edwards Lifesciences Corp Transaction History

Cetera Advisors LLC

$0
Q1 2024

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$72.54 - $95.56 $1.76 Million - $2.32 Million	24,242 Added 175.06%	38,090 $3.64 Million
Q4 2023 Feb 13, 2024	SELL	$61.71 - $77.76 $80,654 - $101,632	-1,307 Reduced 8.62%	13,848 $1.06 Million
Q3 2023 Nov 14, 2023	SELL	$69.28 - $93.38 $25,702 - $34,643	-371 Reduced 2.39%	15,155 $1.05 Million
Q2 2023 Aug 09, 2023	BUY	$81.41 - $94.33 $12,699 - $14,715	156 Added 1.01%	15,526 $1.46 Million
Q1 2023 May 15, 2023	SELL	$74.26 - $84.51 $63,640 - $72,425	-857 Reduced 5.28%	15,370 $1.27 Million
Q4 2022 Feb 14, 2023	SELL	$68.3 - $87.44 $312,199 - $399,688	-4,571 Reduced 21.98%	16,227 $1.21 Million
Q3 2022 Nov 10, 2022	BUY	$82.37 - $107.29 $770,159 - $1 Million	9,350 Added 81.67%	20,798 $2,000
Q2 2022 Aug 11, 2022	BUY	$86.5 - $128.27 $93,766 - $139,044	1,084 Added 10.46%	11,448 $1.09 Million
Q1 2022 May 12, 2022	BUY	$101.96 - $128.34 $132,649 - $166,970	1,301 Added 14.36%	10,364 $1.22 Million
Q4 2021 Feb 14, 2022	SELL	$106.37 - $130.68 $164,341 - $201,900	-1,545 Reduced 14.56%	9,063 $1.17 Million
Q3 2021 Nov 16, 2021	BUY	$102.91 - $122.75 $200,983 - $239,730	1,953 Added 22.56%	10,608 $1.2 Million
Q2 2021 Aug 13, 2021	BUY	$83.84 - $104.76 $134,647 - $168,244	1,606 Added 22.78%	8,655 $896,000
Q1 2021 May 17, 2021	SELL	$78.68 - $90.67 $553,356 - $637,682	-7,033 Reduced 49.94%	7,049 $590,000
Q4 2020 Feb 17, 2021	BUY	$71.69 - $91.23 $52,692 - $67,054	735 Added 5.51%	14,082 $1.29 Million
Q3 2020 Nov 13, 2020	BUY	$67.19 - $87.44 $96,686 - $125,826	1,439 Added 12.08%	13,347 $1.07 Million
Q2 2020 Aug 13, 2020	BUY	$57.54 - $76.95 $685,186 - $916,320	11,908 New	11,908 $823,000
Q1 2020 May 08, 2020	SELL	$52.41 - $81.0 $123,635 - $191,079	-2,359 Closed	0 $0
Q4 2019 Feb 10, 2020	BUY	$71.7 - $82.09 $4,588 - $5,253	64 Added 2.79%	2,359 $548,000
Q3 2019 Nov 06, 2019	SELL	$61.55 - $75.43 $6,278 - $7,693	-102 Reduced 4.26%	2,295 $505,000
Q2 2019 Aug 12, 2019	SELL	$55.74 - $64.41 $1,727 - $1,996	-31 Reduced 1.28%	2,397 $443,000
Q1 2019 May 06, 2019	BUY	$47.89 - $64.05 $37,354 - $49,959	780 Added 47.33%	2,428 $466,000
Q4 2018 Feb 15, 2019	SELL	$46.41 - $56.94 $9,885 - $12,128	-213 Reduced 11.45%	1,648 $251,000
Q3 2018 Nov 14, 2018	BUY	$45.7 - $58.03 $8,683 - $11,025	190 Added 11.37%	1,861 $322,000
Q2 2018 Aug 14, 2018	SELL	$42.45 - $51.3 $1,698 - $2,052	-40 Reduced 2.34%	1,671 $243,000
Q1 2018 May 09, 2018	BUY	$37.19 - $47.45 $63,632 - $81,186	1,711 New	1,711 $239,000

Others Institutions Holding EW

# of Institutions

1,351

Shares Held

455M

Call Options Held

9.76M

Put Options Held

3.92M

Vanguard Group Inc Valley Forge, PA

62.6M
Shares

$4.24 Billion
0.08% of portfolio
Black Rock Inc. New York, NY

51M
Shares

$3.45 Billion
0.11% of portfolio
Wellington Management Group LLP Boston, MA

31.5M
Shares

$2.14 Billion
0.37% of portfolio
State Street Corp Boston, MA

26.3M
Shares

$1.78 Billion
0.07% of portfolio
Geode Capital Management, LLC Boston, MA

13.5M
Shares

$916 Million
0.07% of portfolio

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $41.9B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cetera Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cetera Advisors LLC with notifications on news.

Account